PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

NCT00359008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 336

Last updated 2008-01-15

No results posted yet for this study

Summary

The primary objective of this study is to assess the ability of the PHP \& HPHP to detect newly diagnosed non treated Chorodial neovascularization (CNV) lesion associate with advanced age related Macular Degeneration (AMD) and differentiate them from Early/intermediate/GA AMD

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Ofer Sharon, MD · Notal Vision

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2007-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00359008 on ClinicalTrials.gov